Mission Biocapital

Venture Capital Exempt reporting adviser

Legal name: Bioinnovation Management LLC

Cambridge, MA Website

AUM

$210.9M
Private fund assets

Private funds

1
Venture Capital 1

Private fund assets

$210.9M
Gross asset value

Employees

—

Last Form D raise

Feb 2017
Most recent fund filing

From SEC Form ADV filing (filed Mar 26, 2026). View on SEC

People(6)

Owners and executive officers named on the firm's SEC Form ADV.

D
General Partner, and Director of Bioinnovation Management LLC
E
Managing General Partner and Director, and Series B Member of Bioinnovation Management LLC
J
General Partner and Director and Series B Member of Bioinnovation Management LLC
P
Managing General Partner, CEO, and Series A and B Member of Bioinnovation Management LLC
S
General Partner and Director of Bioinnovation Management LLC
S
Senior Advisor, Director and Series B Member of Bioinnovation Management LLC

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Bioinnovation Capital I LPVenture Capital$210.9M$65.6M12Feb 2017Cold

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
283710
SEC file number
802-107753

Sources